LATEST ALERTS
This week’s regulatory news in brief includes updates from Austria, Belgium, Germany, France, Italy, Switzerland, UK, the US, Mexico, Australia, Colombia, Costa Rica, Uruguay and Israel
The Zimbabwean agriculture minister has officially published a new statutory instrument to regulate the production, procurement, distribution, possession, sale, provision and transportation of industrial hemp
There has been increased interest in secondary markets that has resulted in some positive developments.
A proposal to be voted on by Brazilian legislators in the coming weeks could legalise the growing of hemp for industrial purposes and cannabis for medical use
This week’s regulatory news in brief includes updates from Spain, the UK, the US, Hong Kong, South Africa and Zimbabwe
The Marijuana Opportunity Reinvestment and Expungement (MORE) Act was, of course, always more about cannabis than hemp-derived CBD specifically. And, as previously stated, its chances of passing were slim to none.
There does not seem to be much point in continuing to try to force through bills – particularly given that the Republican-controlled senate and presidency opposes any measures and the limited timeframe before the end of the legislative session.
This week’s regulatory news in brief includes updates from France, Italy, Poland, Sweden, the US, the British Virgin Islands, Argentina, Australia, Ecuador, Israel, the Philippines and Russia
This regulatory report covers all aspects of the regulatory regime for hemp and CBD in Japan, including medical cannabis and import/export laws
This week’s regulatory news in brief includes updates from Czech Republic, France, Germany, Ireland, Lithuania, Malta, Netherlands, Slovakia, Ukraine, the UK, the US, Colombia, Israel and Russia
The US House of Representatives is expected to hold a historic vote this month on a comprehensive cannabis reform bill that supporters embrace for not only decriminalising marijuana but correcting injustices
What should the industry make of the recent paper from 11 industry associations putting forward a unified position on the issues surrounding the potential for CBD to be considered a narcotic? A
More than a dozen CBD businesses have given their backing to an investigation of the impact of CBD on liver toxicity levels in order to provide regulatory authorities in the US with reliable new data
Israel is considering amending the Dangerous Drugs Ordinance, which – if successful – will have a major impact on the market with hemp and CBD products
This week’s regulatory news in brief includes updates from Belgium, Germany, Malta, Canada, the US, Brazil, Chile, Colombia, Indonesia, Israel, New Zealand, Pakistan, Paraguay and Peru
First it’s important to note that the DEA proposals are only in a draft form and are open to comment until 20th October. They have already received a large number of comments, the majority of which appear to be criticising aspects of the proposed regulatory regime that have raised hackles among the industry.
Companies seeking licences to produce hemp in the Chinese province of Yunnan face a tightening of the application process, according to some who have successfully negotiated the concealed hurdles
The pharmaceutical side of the cannabinoid industry continues to grow, with several major announcements expanding treatments and blurring boundaries
CBD-Intel managing director, Tim Phillips, discusses the main facts and issues surrounding CBD and Novel Food status in European markets. He presents the key aspects of the delay, the political issues and the impacts released on the European level and the future challenges for the sector.
Proposed regulations from the US Drug Enforcement Administration (DEA) have riled the hemp and CBD sectors, with opinions divided on what the rule would mean if enacted in its current form
FOR IMMEDIATE RELEASE CBD food products to remain illegal for three years New report from CBD-Intel explores issues surrounding CBD as a novel food Don’t expect to see legal CBD food and drink products before 2023 at the very earliest, a new report from CBD-Intel warns. The use of CBD as a food ingredient has […]
This week’s regulatory news in brief includes updates from the Czech Republic, Sweden, Mexico, the US, Ecuador and Israel
The immediate impact of the decision is a reduction in certainty for CBD firms – not something they need at a time of significantly heightened uncertainty in other areas.
Do not expect European novel food authorisations before the end of 2022 at the very earliest and do not expect generic authorisations to cover non-applicant products, a new report from CBD-Intel warns
Charlotte’s Web has been denied a US trademark on appeal – a ruling that has serious implications for any company in the CBD sector selling food, drink or dietary supplement products in the US
A German company is still waiting to hear from the authorities two months after launching new CBD products that could be considered food supplements
This week’s regulatory news in brief brings updates from France, Germany, Poland, the UK, Canada, Mexico, the US, Argentina, Brazil, Israel, New Zealand, South Africa and Uruguay
Canopy, the Canadian cannabinoid company, has continued to commit heavily to BioSteel, a sports nutrition company in which Canopy now owns the majority share.
A group of tobacco retailers have written to the Italian Tobacconists Federation (FIT) asking it to push for a state monopoly on the sale of CBD flowers
Switzerland plans to launch trials next year as part of a move toward legalising cannabis with high levels of THC – but it could be several years before Swiss users can legally light up a joint
This week’s regulatory news in brief brings updates from Czech Republic, Cyprus, France, Germany, Italy, Switzerland, Canada, Mexico, the US, Israel, Panama, Paraguay, South Africa and Uruguay
The opinion (which is not yet set by the EC but appears to be the way the organisation is thinking) is based on a literal reading of the 1961 UN Narcotics Convention.
Clinical research guidance from the US Food and Drug Administration (FDA) should provide further impetus for cannabis research, which is certain to have an impact on the CBD market
This week’s regulatory news in brief brings updates from the EU, Czech Republic, Germany, Lithuania, Netherlands, Portugal, Canada, Mexico, the US, China, Colombia, Israel, Thailand and Uruguay
The provincial government amended Cannabis Licensing Regulation amendment to allow online and telephone sales of cannabis and CBD products under condition that an exchange of purchased product takes place at a point of sale
Authorities have been very tight lipped about the details of the proposed regulations and little is known beyond the title of the document.
Italian regions are trying to boost the hemp-supply chain through proposed regional rules, funding projects and developing circular economy strategies to make up for the lack of clarifying action at the national level
New Zealand will go to the polls in just under two months to decide on a broad cannabis legalisation referendum that would also encompass fully legalising CBD products
This regulatory report provides a detailed analysis of the current regulations in place in Lithuania, as well as discussing possible future legislation that could change the legal framework
The FDA’s draft guidance on CBD enforcement policy was submitted for review by the White House Office of Management and Budget (OMB) and the OMB has now scheduled meetings with various hemp/CBD stakeholder groups
This week’s regulatory news in brief brings updates from Bosnia and Herzegovina, the US, Ghana, Paraguay and Thailand
Current indications are that the EC is leaning heavily towards the idea that CBD does indeed count as a narcotic under the 1961 Un Convention.
Russia allows industrial hemp to be grown, but with limitations. This report provides an overview of the current regulatory regime in place for CBD and hemp in Russia
Switzerland’s customs authorities returned CHF33m (€30.5m) to CBD producers after the federal supreme court ruled there was no legal basis to tax hemp flowers under the country’s tobacco law
A new government programme will attempt to address one of the industry’s biggest criticisms – the lack of consistency in laboratory test results
This week’s regulatory news in brief brings updates from Belgium, Czech Republic, Germany, Italy, the Netherlands, Poland, Slovakia, the UK, Canada, the US, Australia and Argentina
Current indications are that the EC is leaning heavily towards the idea that CBD does indeed count as a narcotic under the 1961 Un Convention.
Global agricultural giant Pyxus International is among a number of international companies that have expressed interest in venturing into hemp cultivation in Malawi
This week’s regulatory news in brief brings updates from the Netherlands, Poland, Portugal, Switzerland, Mexico, the US, Brazil, Colombia, Ecuador and Israel
Although opponents of the ban had their positive result overthrown by the Seventh Circuit Court of Appeals, the decision is not as bad as a headline might suggest.
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields
